Alnylam Pharmaceuticals Net Income 2006-2019 | ALNY

Alnylam Pharmaceuticals annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Alnylam Pharmaceuticals net income for the quarter ending December 31, 2019 was $-0.276B, a 30.62% increase year-over-year.
  • Alnylam Pharmaceuticals net income for the twelve months ending December 31, 2019 was $-0.886B, a 16.37% increase year-over-year.
  • Alnylam Pharmaceuticals annual net income for 2019 was $-0.886B, a 16.37% increase from 2018.
  • Alnylam Pharmaceuticals annual net income for 2018 was $-0.761B, a 55.13% increase from 2017.
  • Alnylam Pharmaceuticals annual net income for 2017 was $-0.491B, a 19.69% increase from 2016.
Alnylam Pharmaceuticals Annual Net Income
(Millions of US $)
2019 $-886
2018 $-761
2017 $-491
2016 $-410
2015 $-290
2014 $-360
2013 $-89
2012 $-106
2011 $-58
2010 $-44
2009 $-48
2008 $-26
2007 $-85
2006 $-35
2005 $-43
Alnylam Pharmaceuticals Quarterly Net Income
(Millions of US $)
2019-12-31 $-276
2019-09-30 $-209
2019-06-30 $-219
2019-03-31 $-182
2018-12-31 $-211
2018-09-30 $-245
2018-06-30 $-164
2018-03-31 $-141
2017-12-31 $-142
2017-09-30 $-123
2017-06-30 $-118
2017-03-31 $-107
2016-12-31 $-113
2016-09-30 $-104
2016-06-30 $-90
2016-03-31 $-103
2015-12-31 $-91
2015-09-30 $-77
2015-06-30 $-72
2015-03-31 $-51
2014-12-31 $-21
2014-09-30 $-44
2014-06-30 $-44
2014-03-31 $-251
2013-12-31 $-32
2013-09-30 $-30
2013-06-30 $-18
2013-03-31 $-9
2012-12-31 $-62
2012-09-30 $-20
2012-06-30 $-13
2012-03-31 $-11
2011-12-31 $-14
2011-09-30 $-13
2011-06-30 $-14
2011-03-31 $-16
2010-12-31 $-7
2010-09-30 $-10
2010-06-30 $-15
2010-03-31 $-12
2009-12-31 $-8
2009-09-30 $-9
2009-06-30 $-23
2009-03-31 $-8
2008-12-31 $-9
2008-09-30 $-3
2008-06-30 $-13
2008-03-31 $-1
2007-12-31 $2
2007-09-30 $-53
2007-06-30 $-13
2007-03-31 $-22
2006-12-31 $7
2006-09-30 $-7
2006-06-30 $-10
2006-03-31 $-9
2005-12-31 $-14
2005-09-30 $-11
2005-06-30 $-11
2005-03-31 $-7
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.308B $0.220B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.572B 13.67
Gilead Sciences (GILD) United States $94.124B 12.18
CSL (CSLLY) Australia $83.000B 0.00
Vertex Pharmaceuticals (VRTX) United States $61.693B 55.99
Biogen (BIIB) United States $55.070B 9.40
Regeneron Pharmaceuticals (REGN) United States $53.721B 22.75
Illumina (ILMN) United States $40.149B 41.51
Alexion Pharmaceuticals (ALXN) United States $19.942B 9.25
Seattle Genetics (SGEN) United States $19.875B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.874B 34.06
BioMarin Pharmaceutical (BMRN) United States $15.204B 650.00
Genmab (GMAB) Denmark $13.641B 10.70
BioNTech SE (BNTX) Germany $13.214B 0.00
Galapagos (GLPG) Belgium $12.670B 27.67
Genmab (GNMSF) Denmark $11.968B 38.49
Bio-Rad Laboratories (BIO.B) United States $10.513B 49.14
Moderna (MRNA) United States $9.854B 0.00
QIAGEN (QGEN) Netherlands $9.475B 28.89
Exact Sciences (EXAS) United States $8.582B 0.00
BeiGene (BGNE) Cayman Islands $8.019B 0.00
Sarepta Therapeutics (SRPT) United States $7.608B 0.00
Bio-Techne Corp (TECH) United States $7.272B 49.77
Guardant Health (GH) United States $6.569B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.563B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.632B 14.88
Ascendis Pharma (ASND) Denmark $5.376B 0.00
Exelixis (EXEL) United States $5.259B 16.88
Repligen (RGEN) United States $5.028B 91.94
ARGENX SE-ADR (ARGX) Netherlands $5.020B 0.00
Reata Pharmaceuticals (RETA) United States $4.796B 0.00
Acceleron Pharma (XLRN) United States $4.793B 0.00
China Biologic Products (CBPO) China $4.248B 25.22
Vir Biotechnology (VIR) United States $3.763B 0.00
Adaptive Biotechnologies (ADPT) United States $3.509B 0.00
Mirati Therapeutics (MRTX) United States $3.342B 0.00
MorphoSys AG (MOR) Germany $3.232B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.190B 0.00
Blueprint Medicines (BPMC) United States $3.160B 0.00
Global Blood Therapeutics (GBT) United States $3.108B 0.00
Emergent Biosolutions (EBS) United States $3.009B 20.89
Zai Lab (ZLAB) China $2.991B 0.00
NeoGenomics (NEO) United States $2.894B 125.50
Immunomedics (IMMU) United States $2.884B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.580B 43.72
Ultragenyx Pharmaceutical (RARE) United States $2.572B 0.00
Bluebird Bio (BLUE) United States $2.556B 0.00
Halozyme Therapeutics (HALO) United States $2.484B 0.00
Amicus Therapeutics (FOLD) United States $2.377B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.291B 0.00
Alkermes (ALKS) Ireland $2.275B 180.25
RA PHARMCTL INC (RARX) United States $2.272B 0.00
MyoKardia (MYOK) United States $2.183B 0.00
Arena Pharmaceuticals (ARNA) United States $2.110B 5.50
UniQure (QURE) Netherlands $2.100B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.068B 0.00
Principia Biopharma (PRNB) United States $1.960B 0.00
Viela Bio (VIE) United States $1.938B 0.00
Alector (ALEC) United States $1.895B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Denali Therapeutics (DNLI) United States $1.846B 0.00
Fate Therapeutics (FATE) United States $1.687B 0.00
Zymeworks (ZYME) Canada $1.615B 0.00
Arvinas (ARVN) United States $1.575B 0.00
Epizyme (EPZM) United States $1.563B 0.00
Akcea Therapeutics (AKCA) United States $1.445B 31.09
Insmed (INSM) United States $1.439B 0.00
Amarin (AMRN) Ireland $1.429B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.355B 0.00
Zealand Pharma (ZEAL) Denmark $1.244B 0.00
REGENXBIO (RGNX) United States $1.203B 0.00
Ligand Pharmaceuticals (LGND) United States $1.200B 37.29
Coherus BioSciences (CHRS) United States $1.146B 13.63
Editas Medicine (EDIT) United States $1.088B 0.00
Inovio Pharmaceuticals (INO) United States $1.085B 0.00
Twist Bioscience (TWST) United States $1.084B 0.00
Myriad Genetics (MYGN) United States $1.067B 18.83
NextCure (NXTC) United States $1.020B 0.00
PHARMA MAR SA (PHMMF) Spain $1.018B 0.00
Beam Therapeutics (BEAM) United States $0.894B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.852B 0.00
Revance Therapeutics (RVNC) United States $0.844B 0.00
NGM Biopharmaceuticals (NGM) United States $0.835B 0.00
Adverum Biotechnologies (ADVM) United States $0.778B 0.00
I-Mab (IMAB) China $0.742B 0.00
Sangamo Therapeutics (SGMO) United States $0.740B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.724B 0.00
Cytokineticsorporated (CYTK) United States $0.701B 0.00
Novavax (NVAX) United States $0.700B 0.00
Kadmon Holdings (KDMN) United States $0.669B 0.00
Codexis (CDXS) United States $0.657B 0.00
Arcus Biosciences (RCUS) United States $0.638B 0.00
Pharming Group (PHGUF) Netherlands $0.632B 0.00
Athenex (ATNX) United States $0.632B 0.00
Retrophin (RTRX) United States $0.629B 0.00
Cara Therapeutics (CARA) United States $0.617B 0.00
Bellus Health (BLU) Canada $0.600B 0.00
Intellia Therapeutics (NTLA) United States $0.598B 0.00
Intrexon (PGEN) United States $0.577B 0.00
GENFIT S.A (GNFT) France $0.560B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.556B 4.89
Frequency Therapeutics (FREQ) United States $0.551B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.543B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.522B 0.00
Castle Biosciences (CSTL) United States $0.513B 0.00
Compugen (CGEN) Israel $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
ANI Pharmaceuticals (ANIP) United States $0.493B 8.90
Athersys (ATHX) United States $0.492B 0.00
Mesoblast (MESO) Australia $0.471B 0.00
Clovis Oncology (CLVS) United States $0.467B 0.00
AC Immune SA (ACIU) Switzerland $0.467B 11.91
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.458B 0.00
Morphic Holding (MORF) United States $0.447B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.437B 0.00
Heska (HSKA) United States $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.431B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Cel-Sci (CVM) United States $0.423B 0.00
Verastem (VSTM) United States $0.419B 0.00
Vericel (VCEL) United States $0.412B 61.13
Anika Therapeutics (ANIK) United States $0.410B 14.10
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.396B 0.00
Agenus (AGEN) United States $0.396B 0.00
Cellectis S.A (CLLS) France $0.391B 0.00
MiMedx (MDXG) United States $0.386B 0.00
AnaptysBio (ANAB) United States $0.385B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
UROGEN PHARMA (URGN) United States $0.373B 0.00
BioDelivery Sciences (BDSI) United States $0.365B 42.11
Scholar Rock Holding (SRRK) United States $0.361B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.354B 0.00
Merus (MRUS) Netherlands $0.351B 0.00
CytomX Therapeutics (CTMX) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.349B 10.44
Kala Pharmaceuticals (KALA) United States $0.339B 0.00
Sorrento Therapeutics (SRNE) United States $0.334B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.332B 0.00
Puma Biotechnology (PBYI) United States $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.324B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.306B 0.00
Dynavax Technologies (DVAX) United States $0.304B 0.00
Pfenex (PFNX) United States $0.302B 441.00
Avid Bioservices (CDMO) United States $0.289B 0.00
NantKwest (NK) United States $0.284B 0.00
Mersana Therapeutics (MRSN) United States $0.265B 0.00
Kamada (KMDA) Israel $0.260B 10.80
Syros Pharmaceuticals (SYRS) United States $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Albireo Pharma (ALBO) United States $0.245B 0.00
Stemline Therapeutics (STML) United States $0.244B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.242B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.240B 0.00
Geron (GERN) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.221B 0.00
MannKind (MNKD) United States $0.219B 0.00
Gritstone Oncology (GRTS) United States $0.215B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.212B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 1.88
Selecta Biosciences (SELB) United States $0.208B 0.00
Alcobra (ARCT) United States $0.206B 0.00
XOMA (XOMA) United States $0.199B 0.00
ChromaDex (CDXC) United States $0.195B 0.00
Protagonist Therapeutics (PTGX) United States $0.193B 0.00
Starpharma Holdings (SPHRY) Australia $0.186B 0.00
HOOKIPA Pharma (HOOK) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.171B 0.00
VBI Vaccines (VBIV) United States $0.169B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
OSMOTICA PHARM (OSMT) United States $0.164B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Prometic Life Sciences (LMNL) Canada $0.157B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Fortress Biotech (FBIO) United States $0.148B 0.00
Cerecor (CERC) United States $0.143B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Aytu Bioscience (AYTU) United States $0.136B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.134B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Exicure (XCUR) United States $0.129B 0.00
VolitionRX (VNRX) United States $0.128B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 4.87
Theratechnologies (THTX) Canada $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.122B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
AIT Therapeutics (XAIR) United States $0.117B 0.00
IBio (IBIO) United States $0.108B 0.00
Northwest Biotherapeutics (NWBO) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Palatin Technologies (PTN) United States $0.097B 2.65
OvaScience (MLND) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.095B 0.00
Aptinyx (APTX) United States $0.095B 0.00
CorMedix Inc (CRMD) United States $0.094B 0.00
TELA Bio (TELA) United States $0.089B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Five Prime Therapeutics (FPRX) United States $0.083B 0.00
Happiness Biotech Group (HAPP) China $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Cyclerion Therapeutics (CYCN) United States $0.074B 0.00
Eton Pharmaceuticals (ETON) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.070B 4.09
Arbutus Biopharma (ABUS) Canada $0.070B 0.00
Adocia (ADOCY) France $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Synlogic (SYBX) United States $0.055B 0.00
Trevena (TRVN) United States $0.055B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Catalyst Biosciences (CBIO) United States $0.053B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.040B 0.00
Soligenix (SNGX) United States $0.040B 0.00
VIVUS (VVUS) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Cocrystal Pharma (COCP) United States $0.033B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Celsion (CLSN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Unum Therapeutics (UMRX) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Spherix (AIKI) United States $0.002B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00